Abstract
Prolyl oligopeptidase (POP), is an 80-kDa serine protease that hydrolyzes peptides smaller than 30-mer at the carboxyl side of an internal proline-residue. POP is commonly believed to cleave a number of neuropeptides claimed to be involved in learning, memory and mood. While the support to the neuropeptide cleavage theory has been declining, new data suggest novel functions for POP, e.g. as a regulator of protein secretion, α-synuclein aggregation and cell proliferation/differentiation. Intriguingly, many of these novel functions may not depend on the hydrolytic activity of POP. One of the new roles is an involvement of POP in neurotransmission. Indeed, POP has been associated with a variety of different neurotransmitters. According to our previous results, POP is located in GABAergic and cholinergic neurotransmitter systems and in short glutamatergic projection neurons between cortex and thalamus. Based on these findings, POP may be involved in inhibitory and excitatory signal transmission and in the thalamocortical and corticothalamic signalling in the brain. It has also been shown that POP inhibition can affect the functions of neurotransmitters and that the ligands of neurotransmitter receptors can alter the activity of POP. Thus, there is a connection between the neurotransmitters and POP, although the mechanisms and the functional significance of this linkage are still unknown. Here, we will review the data about the connections of POP with conventional neurotransmitter systems and provide an overview of the role of POP in neurotransmission.
Keywords: Brain lesions, immunohistochemistry, neurotransmitters, prolyl oligopeptidase, POP, PEP, rat, stereotaxis, Sarcophaga peregrina, Thyrotropin-releasing hormone, Glutamate, GABA, Serotonin
CNS & Neurological Disorders - Drug Targets
Title: Association of Prolyl Oligopeptidase with Conventional Neurotransmitters in the Brain
Volume: 10 Issue: 3
Author(s): Iida Peltonen, Timo T. Myohanen and Pekka T. Mannisto
Affiliation:
Keywords: Brain lesions, immunohistochemistry, neurotransmitters, prolyl oligopeptidase, POP, PEP, rat, stereotaxis, Sarcophaga peregrina, Thyrotropin-releasing hormone, Glutamate, GABA, Serotonin
Abstract: Prolyl oligopeptidase (POP), is an 80-kDa serine protease that hydrolyzes peptides smaller than 30-mer at the carboxyl side of an internal proline-residue. POP is commonly believed to cleave a number of neuropeptides claimed to be involved in learning, memory and mood. While the support to the neuropeptide cleavage theory has been declining, new data suggest novel functions for POP, e.g. as a regulator of protein secretion, α-synuclein aggregation and cell proliferation/differentiation. Intriguingly, many of these novel functions may not depend on the hydrolytic activity of POP. One of the new roles is an involvement of POP in neurotransmission. Indeed, POP has been associated with a variety of different neurotransmitters. According to our previous results, POP is located in GABAergic and cholinergic neurotransmitter systems and in short glutamatergic projection neurons between cortex and thalamus. Based on these findings, POP may be involved in inhibitory and excitatory signal transmission and in the thalamocortical and corticothalamic signalling in the brain. It has also been shown that POP inhibition can affect the functions of neurotransmitters and that the ligands of neurotransmitter receptors can alter the activity of POP. Thus, there is a connection between the neurotransmitters and POP, although the mechanisms and the functional significance of this linkage are still unknown. Here, we will review the data about the connections of POP with conventional neurotransmitter systems and provide an overview of the role of POP in neurotransmission.
Export Options
About this article
Cite this article as:
Peltonen Iida, T. Myohanen Timo and T. Mannisto Pekka, Association of Prolyl Oligopeptidase with Conventional Neurotransmitters in the Brain, CNS & Neurological Disorders - Drug Targets 2011; 10 (3) . https://dx.doi.org/10.2174/187152711794653887
DOI https://dx.doi.org/10.2174/187152711794653887 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions
Current Pharmaceutical Design Adrenomedullin and Oxidative Stress in Vascular Damage and Metabolic Disease
Current Hypertension Reviews Cerebral Angiogenesis and Expression of Angiogenic Factors in Aging Rats after Exercise
Current Neurovascular Research Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases
Current Drug Targets Mitochondrial Aconitase in Neurodegenerative Disorders: Role of a Metabolism- related Molecule in Neurodegeneration
Current Drug Targets Acetylcholinesterase Inhibitor Donepezil Effects on Plasma β-Hydroxybutyrate Levels in the Treatment of Alzheimer’s Disease
Current Alzheimer Research Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Identification of Bioactive Natural Products by Pharmacophore-Based Virtual Screening
Current Pharmaceutical Design Efficacy and Cardiovascular Safety of GLP-1 Receptor Analogues
Current Drug Safety Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Current Drug Targets Editorial (Thematic Issue: Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention)
Current Neuropharmacology Metabolic Basis of Sporadic Alzeimer’s Disease. Role of Hormones Related to Energy Metabolism
Current Pharmaceutical Design Ramelteon in the Treatment of Delirium: New Perspectives from Reported Findings and a Case Observation
Current Drug Therapy Antioxidants in the Treatment of Diabetes
Current Diabetes Reviews Editorial [Hot topic: A Multi-Targeted Approach for a Complex Multifaceted Disease (Guest Editors: D.W. Shineman and H.M. Fillit)]
Current Alzheimer Research Erythropoietin: Cytoprotection in Vascular and Neuronal Cells
Current Drug Targets - Cardiovascular & Hematological Disorders Cardiomyopathy of Pregnancy
Current Women`s Health Reviews Peptidase Inhibitors as a Possible Therapeutic Strategy for Chagas Disease
Current Enzyme Inhibition Commentary [Research Highlights : Neurotrophic Factor Treatment of Neurological Disorders: The Benefits of a Pleiotropic Treatment Approach]
CNS & Neurological Disorders - Drug Targets Genomic and Molecular Characterization of Alzheimer Disease
Current Psychiatry Reviews